V. Walker

发表

Perturbed IFN-gamma-Jak-signal transducers and activators of transcription signaling in tuberous sclerosis mouse models: synergistic effects of rapamycin-IFN-gamma treatment.

Hongbing Zhang, D. Kwiatkowski, K. Hoffmeister, 2004, Cancer research.

Loss of Tsc 1 or Tsc 2 Induces Vascular Endothelial Growth Factor Production through Mammalian Target of Rapamycin 1

Hongbing Zhang, D. Kwiatkowski, N. el-Hashemite, 2003 .

A mouse model of cardiac rhabdomyoma generated by loss of Tsc1 in ventricular myocytes.

D. Kwiatkowski, J. McMullen, Lynsey M. Meikle, 2005, Human molecular genetics.

Efficacy of a rapamycin analog (CCI-779) and IFN-gamma in tuberous sclerosis mouse models.

Hongbing Zhang, H. Onda, D. Kwiatkowski, 2005, Genes, chromosomes & cancer.

Estrogen enhances whereas tamoxifen retards development of Tsc mouse liver hemangioma: a tumor related to renal angiomyolipoma and pulmonary lymphangioleiomyomatosis.

D. Kwiatkowski, N. el-Hashemite, V. Walker, 2005, Cancer research.

Phthalazinone pyrazoles as potent, selective, and orally bioavailable inhibitors of Aurora-A kinase.

R. Engh, G. Georges, Petra Rueger, 2011, Journal of medicinal chemistry.

Induction of novel Grp75 isoforms by 2-deoxyglucose in human and murine fibroblasts.

J. Selkirk, C. He, B. Merrick, 1997, Cancer letters.

Loss of Tsc1 or Tsc2 induces vascular endothelial growth factor production through mammalian target of rapamycin.

Hongbing Zhang, D. Kwiatkowski, N. el-Hashemite, 2003, Cancer research.

Efficacy of a rapamycin analog (CCI‐779) and IFN‐γ in tuberous sclerosis mouse models

Hongbing Zhang, H. Onda, D. Kwiatkowski, 2005 .

Perturbed IFN-γ-Jak-Signal Transducers and Activators of Transcription Signaling in Tuberous Sclerosis Mouse Models

Hongbing Zhang, D. Kwiatkowski, K. Hoffmeister, 2004, Cancer Research.

Conference Scene: Recent developments in the understanding and treatment of hematological malignancies

M. Campbell, S. Brumskill, V. Walker, 2013 .